Search - tctmd.com

Displaying 201 - 220 of 1332

Sort: Relevancy | Date

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

News Conference News TCT 2020

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

Michael O'Riordan

October 23, 2020

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

News Conference News TCT 2020

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

October 17, 2020

SCOPE I: One-year outcomes of a randomized trial comparing a self-expanding to a balloon-expandable transcatheter aortic valve

Presentation TCT 2020

SCOPE I: One-year outcomes of a randomized trial comparing a self-expanding to a balloon-expandable transcatheter aortic valve

Presenter: Thomas Walther

October 17, 2020

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

News Conference News TCT 2020

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

October 16, 2020

A 2x2 Randomized Trial of Self-Expandable vs Balloon-Expandable Valves and General vs Local Anesthesia in Patients Undergoing Transcatheter Aortic Valve Implantation: 1-year Results

Presentation TCT 2020

SOLVE TAV - A 2x2 Randomized Trial of Self-Expandable vs Balloon-Expandable Valves and General vs Local Anesthesia in Patients Undergoing Transcatheter Aortic Valve Implantation: 1-year Results

Presenter: Hans-Josef Feistritzer

October 16, 2020

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

News Conference News TCT 2020

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

October 15, 2020

A Randomized Evaluation oF the TriGUARD3™ Cerebral Embolic Protection Device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation The REFLECT II Trial

Presentation TCT 2020

A Randomized Evaluation oF the TriGUARD3™ Cerebral Embolic Protection Device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation The REFLECT II Trial

Presenter: Jeffrey W. Moses

October 15, 2020

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

News Conference News TCT 2020

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Michael O'Riordan

October 15, 2020

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

News Conference News TCT 2020

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

October 15, 2020

Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: the SCOPE II randomised clinical trial

Presentation TCT 2020

Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: the SCOPE II randomised clinical trial

Presenter: Corrado Tamburino

October 15, 2020

Aspirin Alone After TAVR Supported by Meta-analysis

News Daily News

Aspirin Alone After TAVR Supported by Meta-analysis

September 29, 2020

TAVR and Infective Endocarditis—Two Studies Address a Shifting Landscape

News Daily News

TAVR and Infective Endocarditis—Two Studies Address a Shifting Landscape

September 14, 2020

Which TAVR Device Is Best? Review Tackles Optimal Selection

News Daily News

Which TAVR Device Is Best? Review Tackles Optimal Selection

Michael O'Riordan

September 09, 2020

Should Guidelines Support TAVR for Low-Risk Patients? Two Views

News Daily News

Should Guidelines Support TAVR for Low-Risk Patients? Two Views

August 17, 2020

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

News Daily News

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

July 27, 2020

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

News Conference News EuroPCR 2020

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

Yael L. Maxwell

July 03, 2020

July 2020 News Roundup

News Daily News

July 2020 News Roundup

July 01, 2020

Device Explants After TAVR Rare but Risky

News Conference News TVT 2020

Device Explants After TAVR Rare but Risky

Michael O'Riordan

June 24, 2020

High TEE Injury Rate in Structural Heart Interventions Warrants Caution

News Daily News

High TEE Injury Rate in Structural Heart Interventions Warrants Caution

Yael L. Maxwell

June 24, 2020

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

News Conference News TVT 2020

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Michael O'Riordan

June 23, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.